Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Tax Provisions (2022 - 2024)

Historic Tax Provisions for Beam Therapeutics (BEAM) over the last 3 years, with Q4 2024 value amounting to $61000.0.

  • Beam Therapeutics' Tax Provisions fell 9564.29% to $61000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $61000.0, marking a year-over-year decrease of 9576.09%. This contributed to the annual value of $100000.0 for FY2024, which is 9285.71% down from last year.
  • Beam Therapeutics' Tax Provisions amounted to $61000.0 in Q4 2024, which was down 9564.29% from $39000.0 recorded in Q2 2024.
  • In the past 5 years, Beam Therapeutics' Tax Provisions registered a high of $2.4 million during Q3 2022, and its lowest value of $39000.0 during Q2 2024.
  • Moreover, its 3-year median value for Tax Provisions was $1.0 million (2022), whereas its average is $982000.0.
  • Per our database at Business Quant, Beam Therapeutics' Tax Provisions soared by 4000.0% in 2023 and then crashed by 9564.29% in 2024.
  • Quarter analysis of 3 years shows Beam Therapeutics' Tax Provisions stood at $1.0 million in 2022, then surged by 40.0% to $1.4 million in 2023, then plummeted by 95.64% to $61000.0 in 2024.
  • Its last three reported values are $61000.0 in Q4 2024, $39000.0 for Q2 2024, and $1.4 million during Q4 2023.